GlaxoSmithKline-funded PhD studentship: Immune Ageing (Fixed Term)
programme is part of CG-AGE, a collaborative project between the Department of Medicine and GlaxoSmithKline, focused on the...
programme is part of CG-AGE, a collaborative project between the Department of Medicine and GlaxoSmithKline, focused on the...
At GSK, we unite science, technology and talent to get ahead of disease together. We are looking for an experienced and strategic HR Business Partner to join our Global Human Resources team, supporting our Development Operations organisatio...
GSK is in an exciting next phase of performance with three clear priorities – deliver growth, accelerate R&D and simplify how we work. Internal Communications plays a key role in engaging our people to achieve the opportunity we have ahead ...
ViiV HR Business Leader The posting period will end on the 29th of July in 2026 Business Introduction: ViiV Healthcare is a global specialty HIV company, the only one that is 100% focused on researching and delivering new medicines fo...
Interventional Study Scientist Medical Director Locations – GSK HQ UK, New Oxford Street & USA - Upper Providence/ Waltham MA Reports to: Head of Interventional & Supported Studies Join GSK's Medical Affairs team and be part of a glob...
Product Director, Pattern & AI Driven Automation Fixed Term Contract - 18 Months. GSK remains committed to achieving bold commercial ambitions for the future. By 2031, we aim to deliver £40 billion in annual sales, leveraging our existi...
The External Manufacturing-Drug Product (EM-DP) Project Specialist is accountable for providing project oversight for Contract Manufacturing Organisations (CMOs) through the Procurement, Quality, Technical, Supply, + (PQTS +) team. The Pr...
The Capital Projects Engineering Manager provides single-point leadership and accountability for the capital projects engineering team and the end-to-end capital project process across the Barnard Castle manufacturing site. This role repo...
GSK remains committed to achieving bold commercial ambitions for the future. By 2031, we aim to deliver £40 billion in annual sales, leveraging our existing strong performance momentum to significantly increase our positive impact on the he...
We manufacture and supply reliable, high-quality medicines and vaccines to meet patients’ needs and drive our performance. Our network of 37 medicines and vaccines manufacturing sites delivered 1.7 billion packs of medicines and 409 millio...